Pediatric Neurology

Latest News

Short-Term Exposure to General Anesthesia in Infancy Does Not Affect Neurodevelopment

Researchers reported full results of the 5-year GAS trial, the first randomized controlled trial to assess the effects of general anesthesia in infancy on neurodevelopmental outcomes.

Alterations in Cord Blood microRNAs May Predict Hypoxic-Ischemic Encephalopathy, Perinatal Asphyxia in Neonates

In this analysis, investigators examined alterations in the expression of umbilical cord whole-blood miRNAs.

Screen Time Linked to Poorer Child Developmental Performance

Screen time is associated with poorer performance on developmental screening tests among young children.

Auditory Naming Improves Naming Assessment in Children With Epilepsy

Investigators examined whether noninvasive language tasks developed for children could identify the hemisphere of seizure onset in pediatric epilepsy.

Buprenorphine May Be an Optimal Treatment for Neonatal Abstinence Syndrome

Buprenorphine appears to be the optimal pharmacological treatment for neonatal abstinence syndrome.

Early vs Late Caffeine Therapy Reduces Neurodevelopmental Impairment in Preemies

Researchers compared the benefits of caffeine administration in premature infants who started therapy with the first 2 days of birth vs premature infants who started caffeine therapy after the third day.

Nerve Transfer Promising for Acute Flaccid Myelitis Patients

Two patients diagnosed with acute flaccid myelitis and upper-extremity neuropathy who were treated with peripheral nerve transfer continue to demonstrate functional recovery at 2 years.

Temporary Impairment in HRQOL After Teen Sports Concussion

Adolescent sports-related concussion (SRC) is associated with temporary impairments in health-related quality of life.

Glasgow Coma, AVPU Scales Have Limited Usability for Assessing Level of Consciousness in Pediatric Head Injury

Investigators examined the use and equivalence of the Glasgow Coma Scale and the Alert, Voice, Pain, Unresponsive scale in children with head injury.

First Generic Version of Sabril Tablets Gets FDA Approval

As treatment with vigabatrin may be associated with permanent vision loss, the generic tablets are also part of a single shared-system Risk Evaluation and Mitigation Strategy (REMS) program to ensure the product is used safely.